drugset / Trial / NCT05416957

Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

NCT05416957

Phase 1 Completed 24 enrolled Seasons Biotechnology (Taizhou) Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

An open label, randomized, two-period, two-treatment \[Treatment A (Investigational product administration under fasting condition) vs Treatment B (Investigational product administration under fed condition)\], two-sequence, crossover, balanced, single dose oral food effect bioavailability study.

Timeline

Start
2022-09-18
Primary completion
2022-10-27
Completion
2022-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 20 mg Oral